GITNUX MARKETDATA
Browse Our Category
Science Research
Latest update:
Favorite Color Statistics
In Favorite Color’s latest snapshot, 29% of people name their favorite as Blue, but the real surprise is how preferences split sharply by age and region instead of clustering the way you’d expect. If you’ve ever wondered why a “safe” favorite doesn’t stay safe across demographics, this page is where the patterns snap into focus.
Mew Statistics
Mew’s statistics for Mew Players reveal a sharp swing between expectations and reality, with the 2026 outlook up against the latest hard results. See how the newest figures change the way you should think about value, performance, and risk, not just what sounds good on paper.
Nhst Statistics
NIHST statistics track how NhsT’s most important measures are shifting, with the latest 2026 figures showing a noticeable change in what actually moves performance. See the specific contrasts behind the headline numbers, so you understand where progress is real and where it stalls.
Clinical Research Industry Statistics
With a projected 1.6% CAGR from 2024 to 2034, the global clinical trials market looks set for steady expansion, yet the details are where momentum stalls, since 48% of trials register unclear or missing primary endpoint definitions and 1.9% are suspended or terminated for insufficient recruitment. This page turns those frictions into operational takeaways, from 12.4 month median timelines in ClinicalTrials.gov to the shift toward centralized and risk based monitoring and the scale of 5.3 million CT.gov API records available as of 2024 releases.
Stem Cell Statistics
Stem cell work now spans everything from a US$71.3 billion regenerative medicine market projected by 2032 to 1,225 registered stem cell therapy clinical trials in ClinicalTrials.gov as of 2024-01-01, with trial outcomes ranging up to a 60 percent 1 year overall survival after HSCT. The page also tracks the build side of cell therapy, including a US$0.6 million median preclinical to phase 1 CAR T development cost and 10 CFU per mL mycoplasma testing sensitivity, so you can see where promise meets manufacturing and QC reality.
Crispr Statistics
Get a sharp, numbers first look at how CRISPR output has shifted in the last year, from who is running the largest edits to what those changes are doing in real terms. You will see the 2026 contrasts that matter most, where the speed of editing and the quality of results are pulling apart in unexpected ways.
Life Science Research Industry Statistics
See how 2024 forecasts and 2025 tuned timelines reshape life science execution, from CRO growth to 43% of clinical trials now using electronic data capture and the shift toward cloud data platforms. The page connects economics, regulatory reality, and lab automation with concrete figures including US$281.1 billion by 2032 and measurable gains like up to 60% faster robotic sample preparation, so you can spot where productivity and compliance are likely to pull ahead.
Clinical Trials Industry Statistics
The global clinical trials market is projected to hit $73.2 billion in 2024 with an 11.8% CAGR through 2032, but the real story is how growth is reshaping every bottleneck from CROs and site management to eCOA and digital data capture. This page connects the expansion with operational reality like higher-than-expected protocol and monitoring demands, rising tech adoption, and shifting regulatory expectations tied to warning letters and inspection outcomes.
Animal Statistics
US veterinary spending is projected to be $135.9 billion in 2023, while the global pet care services market is heading from $97.5 billion in 2022 toward $159.5 billion by 2030, a gap that helps explain why animal care, diagnostics, and vaccines are accelerating together. From 59,000 estimated rabies deaths to a 4.95 million AMR mortality burden linked across human and animal health, this page connects pet trends with One Health stakes you cannot afford to ignore.
R&D Statistics
Global R&D intensity ranges from 0.74% of GDP in India to 5.08% in South Korea, while OECD GERD reached $1,089.6 billion in 2022 and EU R&D spending climbed to €436.5 billion, alongside a rare policy benchmark where R&D tax incentives average 0.12% of GDP across OECD countries. See how these spending gaps connect to tangible outputs like patent filings and long run economic gains, where public R&D is estimated to deliver 20% to 50% internal rates of return and US studies link each $1 of R&D to $2 to $3 in added output.
AI Research Statistics
Training compute for frontier ML is now at GPT-4 scale, estimated around 2×10^25 FLOPs, while inference compute is rising even faster than training. Pair that with the supply chain reality of 3.5M NVIDIA H100 GPUs shipped by 2024 and AI data centers projected to consume 8% of US electricity by 2030, and you get the tension between exponential compute and tightening power and hardware constraints.
Gain Of Function Research Statistics
Gain of function funding and incident tracking is split at the seams, with U.S. agencies awarding over $1.5 billion from 2003 to 2020 and reporting 197 select agent lab incidents where 20% were linked to gain of function, yet governance reforms still lag. See how the picture changes across 2000 to 2020 global output, where the U.S. funded 68% of gain of function papers, and how major budgets and oversight shifts continue to shape what counts as high risk and what gets reported.
Genetic Genealogy Statistics
See how modern DNA databases and ancestry models reshape family history, from 98% of self identified White Americans with less than 2% African ancestry to the 70% accuracy drop beyond six generations, while tools can still place many adoptee, endogamy, and close cousin puzzles within reach. You also get the current scale of testing and matching, including AncestryDNA surpassing 22 million samples by 2022 and Nebula Genomics sequencing 100,000 full genomes by 2023, plus the surprising proof points like 99% Neanderthal inheritance in non Africans and shared DNA patterns that make “who’s related” measurable.
Cancer Clinical Trial Participation Statistics
Enrollment remains uneven even as gaps are getting smaller, with seniors over 70 making up only 12% of trial participants despite 40% of diagnoses and community programs enrolling far fewer patients than academic centers. See how race, income, distance, and trial type combine into stark contrasts such as 3.6% of US adults joining therapeutic trials and a 51% drop in enrollment when travel takes more than two hours.
Irb Statistics
IRB’s latest reported FY2023 performance pairs 24.3% revenue growth to INR 7,248.72 crore with an EBITDA margin jump to 43.1%, driven by higher toll collections and construction execution. If you are looking for what’s really moving the bottom line, the page also tracks how debt-to-equity improved to 0.92, finance costs fell to INR 1,320.45 crore, and toll revenue scaled to INR 4,962.30 crore across 18 operational projects.
Lasers Photonics Industry Statistics
From fiber lasers at 45% of total laser revenue in 2022 to surgical lasers used in 15 million procedures worldwide in 2023 and LiDAR shipments up 40% in 2023, this page connects where demand spikes with where technology breakthroughs are actually landing. You get an at-a-glance read on the full stack from 60% of additive manufacturing energy sourcing to 35% EUV market contribution and the $25.33 billion laser market projected for 2028.
Life Sciences Tools Industry Statistics
Global life sciences tools revenue is projected to jump from USD 95.2 billion in 2024 to USD 142.8 billion by 2032, with consumables set to accelerate toward USD 78.4 billion by 2030, all while the US still commands 42.3% of market value. The page also pinpoints how power concentrates across platforms and regions, from Illumina’s 65% NGS share to China reaching 18.5% global share valued at USD 17.9 billion, so you can see where growth is coming from and who is winning the next lab workflow shift.
Genome Statistics
From 7,000 SNPs tied to disease risk and 99.9% detection of trisomy 21 by NIPT, to liquid biopsy genome sequencing that catches 87% of stage I cancers, this page turns modern genomics into clear, decision ready benchmarks. You will also see why CRISPR and precision therapy are starting to shift outcomes, while genome scale facts like 3.2 billion base pairs and 1.5% protein coding explain what we measure when we say “whole genome.”
Social Science Statistics
Violent crime and incarceration trends stand out starkly, from the U.S. violent crime rate at 380.7 per 100,000 to South Africa’s murder rate of 45 per 100,000 and the U.S. jail population at 2.1 million with 70% pretrial. Add shifting perceptions and unequal impacts, including crime fears and mental health pressures alongside education and inequality measures, and you get a snapshot that helps explain not just what happened but why people respond the way they do.
Lab Testing Industry Statistics
See how a global clinical laboratory services market headed for USD 421.5 billion by 2032 at a 5.9% CAGR is reshaping testing demand, from molecular diagnostics growing at 10.5% to POCT set to rise 9.8% by 2029. The page also spotlights who is winning market share, where automation is accelerating workflow at 7.2% CAGR, and why faster turnaround is increasingly a competitive weapon rather than a footnote.